Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Kidney Injury | 10 | 2019 | 1941 | 1.140 |
Why?
|
Trypanosomiasis, African | 4 | 2014 | 28 | 0.880 |
Why?
|
Variant Surface Glycoproteins, Trypanosoma | 2 | 2018 | 9 | 0.680 |
Why?
|
Antihypertensive Agents | 3 | 2018 | 2039 | 0.620 |
Why?
|
Antibodies, Protozoan | 2 | 2018 | 251 | 0.590 |
Why?
|
Trypanosoma congolense | 1 | 2014 | 2 | 0.510 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2015 | 110 | 0.490 |
Why?
|
Cardiac Tamponade | 1 | 2015 | 173 | 0.470 |
Why?
|
Aorta, Abdominal | 5 | 2018 | 645 | 0.460 |
Why?
|
Renin-Angiotensin System | 1 | 2018 | 763 | 0.460 |
Why?
|
Hypertension | 9 | 2018 | 8431 | 0.450 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2014 | 230 | 0.450 |
Why?
|
Antigens, Protozoan | 2 | 2014 | 322 | 0.440 |
Why?
|
Pericardial Effusion | 1 | 2015 | 241 | 0.430 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2018 | 919 | 0.430 |
Why?
|
Cardiac Surgical Procedures | 2 | 2017 | 3517 | 0.420 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1510 | 0.400 |
Why?
|
Ibuprofen | 1 | 2013 | 235 | 0.400 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 3863 | 0.400 |
Why?
|
Nephrolithiasis | 3 | 2017 | 106 | 0.390 |
Why?
|
Kidney Function Tests | 2 | 2017 | 681 | 0.380 |
Why?
|
Hypoglycemia | 1 | 2017 | 855 | 0.360 |
Why?
|
Oxygen Consumption | 1 | 2016 | 1871 | 0.350 |
Why?
|
Hyperglycemia | 1 | 2017 | 1357 | 0.320 |
Why?
|
Renal Replacement Therapy | 3 | 2019 | 260 | 0.320 |
Why?
|
Nephrocalcinosis | 2 | 2017 | 46 | 0.290 |
Why?
|
Brain Diseases | 1 | 2016 | 1551 | 0.290 |
Why?
|
Urogenital Abnormalities | 2 | 2020 | 252 | 0.290 |
Why?
|
Heart Arrest | 1 | 2016 | 1458 | 0.270 |
Why?
|
Blood Platelets | 1 | 2016 | 2506 | 0.260 |
Why?
|
Tissue Expansion Devices | 2 | 2018 | 156 | 0.250 |
Why?
|
Critical Care | 1 | 2017 | 2624 | 0.250 |
Why?
|
Proteomics | 2 | 2014 | 3584 | 0.240 |
Why?
|
Cystic Fibrosis | 1 | 2013 | 1177 | 0.240 |
Why?
|
Hypertension, Pulmonary | 1 | 2015 | 1525 | 0.240 |
Why?
|
Proteinuria | 3 | 2013 | 654 | 0.240 |
Why?
|
Nephrotic Syndrome | 2 | 2017 | 384 | 0.230 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2016 | 237 | 0.230 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2277 | 0.220 |
Why?
|
Mitochondria | 1 | 2016 | 3522 | 0.220 |
Why?
|
Blood Glucose | 1 | 2017 | 6237 | 0.220 |
Why?
|
Foramen Ovale, Patent | 2 | 2014 | 222 | 0.200 |
Why?
|
Fibrinolytic Agents | 3 | 2017 | 2149 | 0.200 |
Why?
|
Child, Preschool | 18 | 2020 | 40802 | 0.200 |
Why?
|
Arterial Occlusive Diseases | 2 | 2018 | 792 | 0.200 |
Why?
|
Trypanosoma brucei brucei | 2 | 2018 | 43 | 0.190 |
Why?
|
Pedigree | 5 | 2020 | 4640 | 0.190 |
Why?
|
Postoperative Complications | 3 | 2019 | 15194 | 0.190 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2020 | 68 | 0.180 |
Why?
|
Urinary Tract | 2 | 2020 | 301 | 0.180 |
Why?
|
Aortic Valve Stenosis | 3 | 2018 | 1930 | 0.180 |
Why?
|
Child | 18 | 2020 | 77033 | 0.170 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2019 | 112 | 0.160 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2184 | 0.160 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2019 | 194 | 0.160 |
Why?
|
Mesenteric Arteries | 1 | 2018 | 183 | 0.160 |
Why?
|
Renal Artery | 2 | 2017 | 398 | 0.150 |
Why?
|
Intensive Care Units, Pediatric | 3 | 2019 | 976 | 0.150 |
Why?
|
Receptors, Virus | 2 | 2013 | 648 | 0.150 |
Why?
|
Aortic Diseases | 2 | 2013 | 734 | 0.150 |
Why?
|
Mutation | 6 | 2020 | 29658 | 0.150 |
Why?
|
Septal Occluder Device | 2 | 2014 | 129 | 0.140 |
Why?
|
Kidney Diseases | 1 | 2008 | 2140 | 0.140 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 195 | 0.140 |
Why?
|
Blood Pressure | 3 | 2017 | 8554 | 0.140 |
Why?
|
Feedback, Physiological | 1 | 2018 | 478 | 0.130 |
Why?
|
Anion Transport Proteins | 1 | 2016 | 141 | 0.130 |
Why?
|
Cell Respiration | 1 | 2016 | 203 | 0.130 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2018 | 385 | 0.130 |
Why?
|
Trypanocidal Agents | 1 | 2014 | 38 | 0.130 |
Why?
|
Adolescent | 17 | 2020 | 85405 | 0.120 |
Why?
|
Cattle Diseases | 1 | 2014 | 52 | 0.120 |
Why?
|
Genetic Markers | 2 | 2017 | 2630 | 0.120 |
Why?
|
Creatinine | 1 | 2020 | 1903 | 0.120 |
Why?
|
Infant | 12 | 2020 | 34923 | 0.120 |
Why?
|
Neurofibromatoses | 1 | 2018 | 299 | 0.120 |
Why?
|
Organogenesis | 1 | 2015 | 223 | 0.110 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 630 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1602 | 0.110 |
Why?
|
Humans | 43 | 2021 | 739398 | 0.110 |
Why?
|
Acyltransferases | 1 | 2014 | 290 | 0.110 |
Why?
|
Kidney | 3 | 2020 | 7144 | 0.110 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2014 | 423 | 0.110 |
Why?
|
Mesentery | 1 | 2013 | 205 | 0.110 |
Why?
|
Referral and Consultation | 2 | 2016 | 3514 | 0.110 |
Why?
|
Endovascular Procedures | 2 | 2018 | 1947 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4182 | 0.100 |
Why?
|
Office Visits | 1 | 2016 | 600 | 0.100 |
Why?
|
Heart Defects, Congenital | 2 | 2019 | 4546 | 0.100 |
Why?
|
Tissue Expansion | 1 | 2012 | 160 | 0.100 |
Why?
|
Africa South of the Sahara | 1 | 2014 | 727 | 0.100 |
Why?
|
Resuscitation | 1 | 2016 | 656 | 0.100 |
Why?
|
Tissue Plasminogen Activator | 1 | 2017 | 1263 | 0.090 |
Why?
|
Aortic Coarctation | 1 | 2012 | 275 | 0.090 |
Why?
|
Anticoagulants | 2 | 2017 | 4582 | 0.090 |
Why?
|
Syndrome | 4 | 2018 | 3241 | 0.090 |
Why?
|
Thrombotic Microangiopathies | 1 | 2012 | 131 | 0.090 |
Why?
|
Stroke | 3 | 2021 | 9898 | 0.090 |
Why?
|
Heparin | 1 | 2017 | 1637 | 0.090 |
Why?
|
Random Allocation | 1 | 2014 | 2417 | 0.090 |
Why?
|
Membrane Glycoproteins | 2 | 2013 | 3768 | 0.090 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1735 | 0.090 |
Why?
|
Treatment Outcome | 7 | 2018 | 62693 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 4 | 2018 | 17384 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2020 | 3007 | 0.090 |
Why?
|
Organoids | 1 | 2015 | 687 | 0.080 |
Why?
|
Hospital Mortality | 2 | 2019 | 5305 | 0.080 |
Why?
|
Image Enhancement | 1 | 2020 | 2928 | 0.080 |
Why?
|
Apolipoproteins E | 1 | 2014 | 1437 | 0.080 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 927 | 0.080 |
Why?
|
Cloning, Molecular | 1 | 2014 | 4319 | 0.080 |
Why?
|
Cattle | 1 | 2014 | 3913 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6478 | 0.080 |
Why?
|
Hospital Costs | 1 | 2014 | 982 | 0.080 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 2155 | 0.080 |
Why?
|
Pluripotent Stem Cells | 1 | 2015 | 791 | 0.080 |
Why?
|
Male | 24 | 2020 | 349022 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3614 | 0.070 |
Why?
|
Heredity | 2 | 2017 | 153 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2018 | 14740 | 0.070 |
Why?
|
Lipocalins | 1 | 2008 | 170 | 0.070 |
Why?
|
Acute-Phase Proteins | 1 | 2008 | 261 | 0.070 |
Why?
|
Contrast Media | 1 | 2020 | 5293 | 0.070 |
Why?
|
Interleukin-18 | 1 | 2008 | 248 | 0.070 |
Why?
|
Female | 24 | 2020 | 378853 | 0.070 |
Why?
|
Swine | 1 | 2016 | 5901 | 0.070 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2008 | 300 | 0.070 |
Why?
|
Molecular Weight | 1 | 2008 | 2257 | 0.070 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6397 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1934 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2019 | 76631 | 0.060 |
Why?
|
Animals | 9 | 2020 | 168368 | 0.060 |
Why?
|
Aorta | 1 | 2013 | 2048 | 0.060 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4935 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2016 | 2896 | 0.060 |
Why?
|
Pyrazoles | 1 | 2014 | 1963 | 0.060 |
Why?
|
Vascular Surgical Procedures | 1 | 2013 | 1471 | 0.060 |
Why?
|
Glycosylation | 2 | 2018 | 1125 | 0.060 |
Why?
|
Genetic Association Studies | 3 | 2018 | 2694 | 0.060 |
Why?
|
Albuminuria | 1 | 2008 | 692 | 0.060 |
Why?
|
Thrombosis | 1 | 2017 | 2961 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9622 | 0.060 |
Why?
|
Risk Factors | 6 | 2019 | 71974 | 0.050 |
Why?
|
Escherichia coli | 1 | 2014 | 4220 | 0.050 |
Why?
|
ROC Curve | 3 | 2016 | 3526 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 3066 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18349 | 0.050 |
Why?
|
Gene Expression | 1 | 2014 | 7788 | 0.050 |
Why?
|
Pediatrics | 1 | 2016 | 3454 | 0.050 |
Why?
|
Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
Prognosis | 6 | 2018 | 28901 | 0.050 |
Why?
|
Age of Onset | 2 | 2017 | 3263 | 0.050 |
Why?
|
Transcription Factors | 1 | 2020 | 12120 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10945 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3694 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2017 | 15036 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2017 | 4426 | 0.050 |
Why?
|
Adult | 9 | 2018 | 213394 | 0.050 |
Why?
|
Young Adult | 6 | 2017 | 56255 | 0.040 |
Why?
|
Pilot Projects | 1 | 2013 | 8275 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2017 | 25470 | 0.040 |
Why?
|
Constriction, Pathologic | 2 | 2013 | 1096 | 0.040 |
Why?
|
Heart Diseases | 1 | 2012 | 2782 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2018 | 2110 | 0.040 |
Why?
|
Protein Conformation | 2 | 2018 | 4012 | 0.040 |
Why?
|
Larva | 1 | 2020 | 512 | 0.040 |
Why?
|
Area Under Curve | 2 | 2016 | 1655 | 0.040 |
Why?
|
Xenopus | 1 | 2020 | 711 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4220 | 0.040 |
Why?
|
Cohort Studies | 3 | 2018 | 40389 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2216 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3497 | 0.040 |
Why?
|
Phenotype | 4 | 2018 | 16301 | 0.040 |
Why?
|
Acute Disease | 1 | 2008 | 7128 | 0.040 |
Why?
|
Duffy Blood-Group System | 1 | 1997 | 58 | 0.040 |
Why?
|
Collateral Circulation | 1 | 2018 | 287 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18003 | 0.040 |
Why?
|
Lung | 1 | 2015 | 9782 | 0.030 |
Why?
|
Aortography | 1 | 2018 | 429 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 2020 | 2028 | 0.030 |
Why?
|
Trypanosoma brucei gambiense | 1 | 2014 | 6 | 0.030 |
Why?
|
Agglutination Tests | 1 | 2014 | 41 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2008 | 4555 | 0.030 |
Why?
|
Sulfates | 1 | 2016 | 386 | 0.030 |
Why?
|
Bicarbonates | 1 | 2016 | 312 | 0.030 |
Why?
|
Mice | 4 | 2020 | 81002 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1528 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2014 | 159 | 0.030 |
Why?
|
Endoderm | 1 | 2015 | 150 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3571 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 983 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2014 | 464 | 0.030 |
Why?
|
Heterozygote | 1 | 2020 | 2798 | 0.030 |
Why?
|
Vitamin D-Binding Protein | 1 | 2014 | 130 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2018 | 2015 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 342 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2296 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2119 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2015 | 718 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1683 | 0.030 |
Why?
|
Mesenteric Artery, Superior | 1 | 2013 | 101 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35326 | 0.030 |
Why?
|
Odds Ratio | 2 | 2016 | 9846 | 0.030 |
Why?
|
Protein Folding | 1 | 2016 | 842 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2503 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2016 | 2833 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8605 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2014 | 5462 | 0.020 |
Why?
|
Aminopyridines | 1 | 2014 | 541 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2016 | 851 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1991 | 0.020 |
Why?
|
Angioplasty | 1 | 2013 | 363 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5058 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2687 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3510 | 0.020 |
Why?
|
Family | 1 | 2020 | 3141 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19811 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6113 | 0.020 |
Why?
|
Time Factors | 3 | 2018 | 40050 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2014 | 1150 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 1967 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 3146 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2019 | 1339 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2014 | 1015 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9375 | 0.020 |
Why?
|
Models, Molecular | 1 | 2018 | 5460 | 0.020 |
Why?
|
Erythrocytes | 1 | 1997 | 2453 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1294 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4743 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2015 | 1662 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 23294 | 0.020 |
Why?
|
Central Nervous System | 1 | 2014 | 1362 | 0.020 |
Why?
|
Nephrectomy | 1 | 2013 | 1033 | 0.020 |
Why?
|
Critical Illness | 1 | 2019 | 2656 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6295 | 0.020 |
Why?
|
Genotype | 2 | 2017 | 12951 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2014 | 15511 | 0.020 |
Why?
|
Brain Mapping | 1 | 2021 | 6666 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14558 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2015 | 1869 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2018 | 38942 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4768 | 0.020 |
Why?
|
Ultrasonography | 1 | 2017 | 5941 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13816 | 0.010 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1702 | 0.010 |
Why?
|
Genetic Variation | 1 | 2018 | 6539 | 0.010 |
Why?
|
Middle Aged | 5 | 2014 | 212863 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21694 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8307 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6516 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12237 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1374 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13402 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13237 | 0.010 |
Why?
|
United States | 2 | 2019 | 69573 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15987 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9314 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 20913 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 19220 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15153 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9387 | 0.010 |
Why?
|
Serology | 1 | 1997 | 7 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 9812 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11460 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1997 | 769 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 53037 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20055 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 7897 | 0.010 |
Why?
|
Aged | 2 | 2014 | 162698 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1997 | 6174 | 0.000 |
Why?
|